These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4542 related articles for article (PubMed ID: 18173375)

  • 21. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
    Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
    Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
    Butte MJ; Keir ME; Phamduy TB; Sharpe AH; Freeman GJ
    Immunity; 2007 Jul; 27(1):111-22. PubMed ID: 17629517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance.
    Nishimura H; Honjo T
    Trends Immunol; 2001 May; 22(5):265-8. PubMed ID: 11323285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies.
    Nishimura CD; Pulanco MC; Cui W; Lu L; Zang X
    Trends Mol Med; 2021 Mar; 27(3):207-219. PubMed ID: 33199209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.
    Jurado JO; Alvarez IB; Pasquinelli V; Martínez GJ; Quiroga MF; Abbate E; Musella RM; Chuluyan HE; García VE
    J Immunol; 2008 Jul; 181(1):116-25. PubMed ID: 18566376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.
    Kinter AL; Godbout EJ; McNally JP; Sereti I; Roby GA; O'Shea MA; Fauci AS
    J Immunol; 2008 Nov; 181(10):6738-46. PubMed ID: 18981091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of human PD-L1 and B7-1.
    Butte MJ; Peña-Cruz V; Kim MJ; Freeman GJ; Sharpe AH
    Mol Immunol; 2008 Aug; 45(13):3567-72. PubMed ID: 18585785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmed death-1 targeting can promote allograft survival.
    Ozkaynak E; Wang L; Goodearl A; McDonald K; Qin S; O'Keefe T; Duong T; Smith T; Gutierrez-Ramos JC; Rottman JB; Coyle AJ; Hancock WW
    J Immunol; 2002 Dec; 169(11):6546-53. PubMed ID: 12444166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-L1 Binds to B7-1 Only
    Chaudhri A; Xiao Y; Klee AN; Wang X; Zhu B; Freeman GJ
    Cancer Immunol Res; 2018 Aug; 6(8):921-929. PubMed ID: 29871885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of PD-1 in regulating T-cell immunity.
    Jin HT; Ahmed R; Okazaki T
    Curr Top Microbiol Immunol; 2011; 350():17-37. PubMed ID: 21061197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The STATus of PD-L1 (B7-H1) on tolerogenic APCs.
    Sumpter TL; Thomson AW
    Eur J Immunol; 2011 Feb; 41(2):286-90. PubMed ID: 21267998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta.
    Wei S; Shreiner AB; Takeshita N; Chen L; Zou W; Chang AE
    Cancer Res; 2008 Jul; 68(13):5432-8. PubMed ID: 18593946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
    Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
    J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative co-receptors on lymphocytes.
    Greenwald RJ; Latchman YE; Sharpe AH
    Curr Opin Immunol; 2002 Jun; 14(3):391-6. PubMed ID: 11973140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
    Keir ME; Freeman GJ; Sharpe AH
    J Immunol; 2007 Oct; 179(8):5064-70. PubMed ID: 17911591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
    Carreno BM; Collins M
    Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.
    Park JJ; Omiya R; Matsumura Y; Sakoda Y; Kuramasu A; Augustine MM; Yao S; Tsushima F; Narazaki H; Anand S; Liu Y; Strome SE; Chen L; Tamada K
    Blood; 2010 Aug; 116(8):1291-8. PubMed ID: 20472828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo.
    Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Domenig C; Habicht A; Najafian N; Yagita H; Azuma M; Turka LA; Sayegh MH
    J Immunol; 2005 Mar; 174(6):3408-15. PubMed ID: 15749874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.
    Reynoso ED; Elpek KG; Francisco L; Bronson R; Bellemare-Pelletier A; Sharpe AH; Freeman GJ; Turley SJ
    J Immunol; 2009 Feb; 182(4):2102-12. PubMed ID: 19201863
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Li K; Cheng X; Tilevik A; Davis SJ; Zhu C
    J Biol Chem; 2017 Apr; 292(16):6799-6809. PubMed ID: 28270509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 228.